This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Pathogenesis of type 2 diabetes (NIDDM)

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

The pathogenesis of type 2 diabetes (NIDDM) is poorly understood. Whilst there is clearly a relative insulin deficiency due to a combination of increased insulin resistance and decreased insulin secretion the relative contributions of these two factors varies from individual to individual.

The beta cell mass is reduced by about a half in type 2 diabetes (NIDDM) and necroscopic studies show the presence of an islet amyloid polypeptide in a significant proportion of patients.

Insulin resistance is increased in the peripheral tissues dependent upon insulin for glucose uptake and in the liver where insulin inhibits hepatic gluconeogenesis. These changes in insulin resistance are multifactorial and, at present, far from fully understood.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.